Exploring how coffee affects energy use and caffeine processing
The Effect of Coffee on Energy Expenditure and Caffeine Metabolism
This study tests how drinking coffee affects energy use and how the body processes caffeine in healthy people.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 40 Years |
| Sex | All |
| Sponsor | Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences Academic / other |
| Locations | 1 site (Shenzhen, Guangdong) |
| Trial ID | NCT06712511 on ClinicalTrials.gov |
What this trial studies
This project investigates the relationship between coffee consumption and energy expenditure, as well as how the body metabolizes caffeine. Healthy participants will be recruited and required to abstain from stimulant drinks for 24 hours prior to the experiment. During the study, various physiological parameters such as total energy expenditure, heart rate, and cognitive function will be monitored. Blood and urine samples will be analyzed to measure caffeine levels and its metabolites using advanced chromatography techniques.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults who regularly consume coffee.
Not a fit: Patients with conditions such as diabetes, hypertension, or other specified health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how coffee consumption can enhance energy expenditure, potentially aiding in obesity prevention and treatment.
How similar studies have performed: While there have been studies on caffeine and metabolism, this specific investigation into coffee's effects on energy expenditure is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria： * Healthy adults. * Must be able to drink coffee. Exclusion Criteria: * Diabetes. * Hypoglycemia. * Gout. * Osteoporosis. * Gastric ulcer. * Pancreatitis. * Intestinal obstruction. * Blood phobia. * Pathological hypo or hyper tension. * Impaired glucose tolerance. * Claustrophobia. * HIV,etc.
Where this trial is running
Shenzhen, Guangdong
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences — Shenzhen, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: John R Speakman, PhD
- Email: j.speakman@abdn.ac.uk
- Phone: 15810868669
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.